Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies

View through CrossRef
Psilocybin-assisted therapies (PAT) have been used to treat several issues including obsessive-compulsive disorder (OCD), major depressive disorder (MDD), posttraumatic stress disorder (PTSD), smoking addiction, and anxiety (Grob et al., 2011; Johnson et al., 2014; Kisely et a., 2022; Moreno et al., 2006). If more positive benefits of psilocybin are discovered, psilocybin could become a more mainstream treatment option. Due to this possibility, it is important to understand people’s beliefs about psilocybin and PAT. This descriptive study was conducted to understand the relationship between demographic characteristics and attitudes toward psilocybin and PAT. An anonymous Qualtrics survey was utilized to collect responses from 235 participants. Participants responded to questions regarding demographics, knowledge of psilocybin, previous experience with psychedelics, and attitudes toward PAT. Overall, attitudes towards PAT were relatively positive, but there were some notable differences among groups. Those with more positive attitudes were more likely to be men, democrats, and atheists. However, these differences may be related to sampling sources (e.g., Amazon’s Mechanical Turk). Furthermore, participants with prior knowledge of psilocybin and previous experience with psychedelics had more positive attitudes toward PAT. These findings provide relevant information on what groups may be more open to PAT.
Psi Chi, the International Honor Society in Psychology
Title: Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies
Description:
Psilocybin-assisted therapies (PAT) have been used to treat several issues including obsessive-compulsive disorder (OCD), major depressive disorder (MDD), posttraumatic stress disorder (PTSD), smoking addiction, and anxiety (Grob et al.
, 2011; Johnson et al.
, 2014; Kisely et a.
, 2022; Moreno et al.
, 2006).
If more positive benefits of psilocybin are discovered, psilocybin could become a more mainstream treatment option.
Due to this possibility, it is important to understand people’s beliefs about psilocybin and PAT.
This descriptive study was conducted to understand the relationship between demographic characteristics and attitudes toward psilocybin and PAT.
An anonymous Qualtrics survey was utilized to collect responses from 235 participants.
Participants responded to questions regarding demographics, knowledge of psilocybin, previous experience with psychedelics, and attitudes toward PAT.
Overall, attitudes towards PAT were relatively positive, but there were some notable differences among groups.
Those with more positive attitudes were more likely to be men, democrats, and atheists.
However, these differences may be related to sampling sources (e.
g.
, Amazon’s Mechanical Turk).
Furthermore, participants with prior knowledge of psilocybin and previous experience with psychedelics had more positive attitudes toward PAT.
These findings provide relevant information on what groups may be more open to PAT.

Related Results

How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change
How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change
Although psilocybin therapy is currently receiving attention as a novel intervention for a wide range of mental health concerns, limited research has examined the underlying psycho...
Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms
Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms
ABSTRACTDemand for more efficacious antidepressants, particularly those with a rapid onset of action, has resulted in a reevaluation of psychedelic drugs for their therapeutic pote...
Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder
Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder
Psilocybin, a naturally occurring psychedelic compound, has received attention as a novel therapeutic option for major depressive disorder (MDD), particularly in cases where tradit...
Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders
Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders
Introduction: Substance use disorder (SUD) and alcohol use disorder (AUD) are major public health crises, affecting millions of Americans. Current treatment options include behavio...
Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways
Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways
Abstract Psilocybin is a psychedelic tryptamine that has emerged as a potential candidate for the treatment of a variety of conditions, including...
Alternative therapy for neurological and psychiatric disorders using psilocybin
Alternative therapy for neurological and psychiatric disorders using psilocybin
Introduction: In recent years, psilocybin has been explored as an alternative therapy for neurological and psychiatric disorders, such as depression, anxiety, post-traumatic stress...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...

Back to Top